At a Glance
Venrock Healthcare operates as the specialized healthcare investment arm of Venrock, the venture capital firm originally established as the investment vehicle for the Rockefeller family fortune. While Venrock itself traces back to 1969, the firm's healthcare focus has become increasingly pronounced over the past two decades, culminating in a dedicated healthcare practice that manages approximately $3 billion in assets under management across the broader Venrock platform. The firm occupies a distinctive position in healthcare venture capital, leveraging both significant financial resources and deep institutional relationships built over more than five decades of investing. Venrock Healthcare concentrates its investments across two primary sectors: biotechnology and digital health, typically entering at seed through Series B stages. The firm has built a reputation for backing transformative healthcare companies, with notable portfolio companies including Foundation Medicine, which was acquired by Roche for $2.4 billion in 2018, and Castlight Health, which went public in 2014. In biotechnology, Venrock has invested in companies like Moderna, participating in early rounds before the company's high-profile IPO and COVID-19 vaccine success. The firm's digital health investments span telemedicine, health data analytics, and care delivery platforms. Venrock Healthcare's investment approach reflects both the traditional venture capital model and the unique advantages of the Rockefeller legacy, including access to extensive networks in academia, government, and industry. The firm typically invests $2-15 million in initial rounds, with the capacity for substantial follow-on investments as portfolio companies scale. Their portfolio construction emphasizes companies with strong intellectual property positions, regulatory pathways to market, and experienced management teams. The healthcare team works closely with Venrock's broader platform, which includes investments in technology and energy sectors, allowing for cross-pollination of insights and resources. Venrock Healthcare's market position is strengthened by its ability to participate in larger syndicated deals while also leading smaller, specialized rounds where their domain expertise provides competitive advantage. The firm's longevity and institutional relationships provide portfolio companies with access to strategic partners, potential acquirers, and follow-on investors throughout the healthcare ecosystem.
“Backs transformative healthcare and life sciences companies from discovery through growth.”
Venrock Healthcare's investment team combines scientific expertise with operational experience in healthcare companies. The team includes partners with backgrounds spanning biotechnology research, digital health entrepreneurship, and healthcare services. Several team members hold advanced degrees in life sciences and have prior experience as entrepreneurs or executives in healthcare companies. The firm's investment professionals work closely with a network of advisors including prominent physicians, researchers, and former healthcare executives who provide due diligence support and ongoing guidance to portfolio companies. This combination of investment experience and domain expertise enables Venrock Healthcare to evaluate both the scientific merit and commercial potential of healthcare innovations.
Venrock has raised multiple funds since its 1969 founding, with healthcare investments becoming an increasingly significant portion of the firm's strategy over the past 15 years. The firm typically raises new funds every 3-4 years, with recent funds ranging from $450 million to $500 million in size. While Venrock operates as a single firm rather than separate healthcare-focused funds, healthcare investments now represent a majority of the firm's deployment strategy, reflecting both market opportunities and the team's specialized expertise in the sector.
Venrock Healthcare primarily invests at the Seed, Series A, Series B+ stages. This means they focus on companies that are building their initial product and finding product-market fit.
Venrock Healthcare is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
Venrock Healthcare focuses on investments in Biotech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
Venrock Healthcare's typical investment check size ranges from $1M to $30M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Venrock Healthcare manages approximately $3B+ (total) in assets under management (AUM) across their funds.